Christopher Wooden, Senior Director, Business Marketing, IQVIA
A critical aspect of any pharma/life sciences commercialization strategy is to develop and deploy effective and meaningful ways to engage, inform and build trust with healthcare providers (HCPs)….
Continue Reading
NHS England has been informed by lawyers that key aspects of its federated data platform (FDP) lack a legal basis, meaning that unless it can find a solution, citizens must be allowed to opt…
Continue Reading
Melissa Easy, VP & General Manager of Clinical Technologies, IQVIA
The clinical trial landscape has greatly benefited from technological innovations over the past few decades. Innovation has expanded remote monitoring capabilities, patient recruitment tactics and…
Continue Reading
The modern landscape of clinical trials is expanding to include hybrid and decentralized approaches to conducting research. As the methods of conducting clinical trials diversify, clinical trial logistics also increase in complexity. In 2024,…
Continue Reading
Dr. Jayawant Fuke, Senior Director of Lifecycle Safety, IQVI Hye Jin Choi, R. Ph., Sr. Director of Regulatory Affairs and Drug Development Solutions, IQVIA Asia Pacific The biopharmaceutical market within the Japan and Asia-Pacific…
Continue Reading
What You Should Know:
– A new study by Avalere commissioned by the Physicians Advocacy Institute (PAI) paints a clear picture: the landscape of US medical practice ownership is shifting dramatically. As of January 2024,…
Continue Reading
IQVIA, a global provider of advanced analytics, clinical research services and technology solutions, announced it has expanded its partnership with tech company Salesforce to help expand its customer engagement platform for the life sciences…
Continue Reading
Scott Fonseca, Sr. Director of Business Development at IQVIA
The healthcare industry is no stranger to workforce shortages, and the pharmaceutical industry may be next to experience disruptions brought on by labor challenges. According to…
Continue Reading
NHS England has confirmed it will republish its patient data contracts with Palantir and IQVIA with fewer redactions, following legal action by Good Law Project.NHSE published a heavily redacted contract with Palantir to run…
Continue Reading
The Good Law Project has taken legal action over NHS England’s heavily redacted contract with US data giant Palantir, which was chosen in November to operate the new Federated Data Platform for the health…
Continue Reading
